• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

SILENCE THERAPEUTICS PLC

Notes

No. Proposition For Against Abstain
1

TO RE-APPOINT AS A DIRECTOR DAVE LEMUS, WHO RETIRES IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION

2

TO RE-APPOINT AS A DIRECTOR TIM MCINERNEY, WHO RETIRES IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION

3

TO RE-APPOINT AS A DIRECTOR IAIN ROSS, WHO RETIRES IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION

4

TO RE-APPOINT AS A DIRECTOR CRAIG TOOMAN, WHO RETIRES IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION

5

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE ATTACHED PROXY STATEMENT

6

TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS - ONE YEAR

7

TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS - TWO YEARS

8

TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS - THREE YEARS

9

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, AS OUR U.S. INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025

10

TO RE-APPOINT PRICEWATERHOUSECOOPERS LLP, AS OUR U.K. STATUTORY AUDITORS

11

TO AUTHORIZE THE AUDIT AND RISK COMMITTEE TO DETERMINE OUR U.K. STATUTORY AUDITORS REMUNERATION FOR THE YEAR ENDING DECEMBER 31, 2025

12

TO RECEIVE AND ADOPT OUR U.K. STATUTORY ANNUAL ACCOUNTS AND AND REPORTS FOR THE YEAR ENDED DECEMBER 31, 2024

13

TO APPROVE OUR DIRECTORS REMUNERATION REPORT FOR THE YEAR ENDED DECEMBER 31, 2024

14

THAT, IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION, ARTICLE 159 OF THE ARTICLES OF ASSOCIATION SHALL APPLY WITH EFFECT FROM THE CONCLUSION OF THIS AGM

15

THAT THE DRAFT ARTICLES OF ASSOCIATION BE ADOPTED AS THE ARTICLES OF ASSOCIATION OF THE COMPANY IN SUBSTITUTION FOR THE EXISTING ARTICLES